ESR1 and breast cancer: Basically, a highly aggressive, metastatic subtype is the Triple Negative Breast Cancer (TNBC) which lacks expression of estrogen alpha receptor (ERα), progesterone, and ERBB2 receptors and comprises nearly 15% of breast cancer cases.